The total return over the past 12 months is +186.88% vs. +16.94% for the S&P 500. So far it's up +48.77% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +186.88% | (4.51%) | (42.05%) | N/A | N/A | N/A |
| Total Return CAGR | +186.88% | (4.51%) | (42.05%) | N/A | N/A | N/A |
| Revenue CAGR | (100.00%) | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Century Therapeutics, Inc. (IPSC)
| Year | Start price | End price | IPSC Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $0.99 | $1.48 | +48.77% | +14.51% | +34.26% |
| 2025 | $1.01 | $0.99 | (1.50%) | +17.72% | (19.22%) |
| 2024 | $3.32 | $1.01 | (69.58%) | +24.89% | (94.47%) |
| 2023 | $5.13 | $3.32 | (35.28%) | +26.19% | (61.47%) |
| 2022 | $15.86 | $5.13 | (67.65%) | (18.17%) | (49.48%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
